Analysis of The Cancer Genome Atlas (TCGA) data revealed that GCNT2 levels are significantly higher in primary melanoma samples (n = 103) than in metastatic cases (n = 368) (p < 0.05) (Figure 1a). The gene discussed is GCNT2; the disease is melanoma.